ESPEN Matrix • Intestinal Failure Classification
Functional Type
Pathophysiologic Mechanism
Diagnostic Signature
Type 1
Acute IF
Functional Definition
Short-term (weeks), usually reversible (e.g. post-op ileus).
Mechanism: Enterostomy
No colon in continuity; highest fluid risk.
Guidelines & Evidence
Verified
Last Review: 2026-07-17
When to Use
When to Use
Defining the type and severity of Short Bowel Syndrome (SBS) following extensive intestinal resection
To guide the requirement for long-term Parenteral Nutrition (PN) and intravenous fluids
To categorize patients for specialized pharmacotherapies (e.g., Teduglutide)
Defining Intestinal Failure (IF)
Short Bowel Syndrome is the primary cause of Intestinal Failure (IF). IF is defined as the "reduction in gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes."
How it Works
Anatomical Classifications (Types I–III)
01
Type I: Enterostomy (Jejunostomy). No colon in continuity. Highest risk of fluid loss.
02
Type II: Jejunocolic Anastomosis. Part of the colon in continuity. Moderate fluid/nutrient salvage.
03
Type III: Jejunoileal Anastomosis. Terminal ileum and Ileocaecal Valve (ICV) preserved. Best prognosis.
Functional Staging (ESPEN)
| Type 1 IF | Acute/Short-term (weeks). Usually reversible. |
| Type 2 IF | Prolonged acute (months). Requires complex MDT care. |
| Type 3 IF | Chronic IF (years/life). Requires home parenteral nutrition (HPN). |
The 200 cm Rule
SBS is traditionally defined as a residual small bowel length of < 200 cm (measured from the ligament of Treitz).
Clinical Pearls
Colon in Continuity — The Game Changer
The colon is a massive reservoir for water and electrolyte salvage and can ferment malabsorbed carbohydrates into short-chain fatty acids (SCFAs), providing up to 500–1000 kcal/day. Type II/III patients (with colon) are significantly more likely to achieve "Enteral Autonomy" than Type I patients.
Teduglutide (GLP-2 Analog)
Teduglutide promotes mucosal growth and enhances absorptive capacity. It is typically considered for Type 3 IF patients who have failed to wean from PN after the initial 6–12 month adaptation period.
Clinical Pearls
The "Duodenal Break" and "Ileal Brake" are natural physiological mechanisms that slow transit; their loss in SBS leads to rapid dumping and fluid loss
Hypergastrinemia (acid oversecretion) occurs hyper-acutely after resection and may require high-dose IV PPI for the first 6 months
Preservation of even 50% of the colon is equivalent to adding 50 cm of small bowel length in terms of absorptive capacity
Next Steps
Management Priority
01
Acute Phase (0-3 months): Aggressive fluid/electrolyte replacement; TPN; PPI.
02
Adaptation Phase (3-12 months): Slow introduction of enteral feeds; oral rehydration solutions (ORS).
03
Maintenance Phase (> 12 months): Evaluation for Step-down or GLP-2 therapy.
The Evidence
The Global Consensus
ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults.
Pironi L et al. • Clinical Nutrition. 2015;34(2):171-80. The defining document for SBS terminology.
View Source• . ;
Origins & History
ESPEN
The European Society for Clinical Nutrition and Metabolism. Working groups from across Europe collaborated to unify the terminology of IF, which was previously a "confused" mix of anatomical and functional descriptions.
Last Comprehensive Review: 2026-07-17